Corcept Therapeutics (CORT) Insider Trading & Ownership $71.75 -0.25 (-0.35%) Closing price 04:00 PM EasternExtended Trading$72.22 +0.47 (+0.65%) As of 06:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Corcept Therapeutics (NASDAQ:CORT) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage20.80%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)15Amount OfInsider Selling(Last 12 Months)$44.29M Get CORT Insider Trade Alerts Want to know when executives and insiders are buying or selling Corcept Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address CORT Insider Buying and Selling by Quarter Corcept Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails8/11/2025Daniel N. Swisher, Jr.DirectorSell2,200$72.30$159,060.00 8/8/2025William GuyerInsiderSell35,007$71.77$2,512,452.39 8/5/2025William GuyerInsiderSell14$71.77$1,004.78 8/1/2025Joseph Douglas LyonInsiderSell5,823$67.51$393,110.73 8/1/2025Joseph K BelanoffCEOSell40,000$68.53$2,741,200.00 8/1/2025Sean MaduckInsiderSell35,007$67.79$2,373,124.53 7/18/2025Joseph Douglas LyonInsiderSell200$73.40$14,680.00 7/18/2025Sean MaduckInsiderSell473$73.44$34,737.12 7/18/2025William GuyerInsiderSell500$73.44$36,720.00 7/17/2025Joseph Douglas LyonInsiderSell3,877$73.48$284,881.96 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 7/17/2025Joseph K BelanoffCEOSell615$73.69$45,319.35 7/17/2025Sean MaduckInsiderSell4,315$73.48$317,066.20 7/17/2025William GuyerInsiderSell4,379$73.48$321,768.92 7/10/2025Daniel N. Swisher, Jr.DirectorSell2,200$71.08$156,376.00 7/1/2025Joseph Douglas LyonInsiderSell100$73.50$7,350.00 7/1/2025Sean MaduckInsiderSell205$73.45$15,057.25 7/1/2025William GuyerInsiderSell100$73.50$7,350.00 6/10/2025Daniel N. Swisher, Jr.DirectorSell2,200$70.61$155,342.00 6/10/2025William GuyerInsiderSell20,000$72.42$1,448,400.00 6/2/2025Joseph Douglas LyonInsiderSell5,000$78.04$390,200.00 6/2/2025Joseph K BelanoffCEOSell40,000$82.86$3,314,400.00 6/2/2025Sean MaduckInsiderSell20,000$79.08$1,581,600.00 5/16/2025David L. MahoneyDirectorSell27,352$74.23$2,030,338.96 5/16/2025William GuyerInsiderSell32,262$74.17$2,392,872.54 5/12/2025Daniel N. Swisher, Jr.DirectorSell2,200$72.06$158,532.00 5/6/2025William GuyerInsiderSell7,060$74.31$524,628.60 5/2/2025Joseph K BelanoffCEOSell40,000$72.90$2,916,000.00 5/2/2025Sean MaduckInsiderSell26,554$72.23$1,917,995.42 4/10/2025Daniel N. Swisher, Jr.DirectorSell2,200$70.22$154,484.00 3/31/2025Joseph K BelanoffCEOSell35,102$94.72$3,324,861.44 3/31/2025Sean MaduckInsiderSell100,000$100.54$10,054,000.00 3/24/2025Joseph Douglas LyonInsiderSell421$60.58$25,504.18 3/24/2025Joseph K BelanoffCEOSell1,974$60.83$120,078.42 3/3/2025Joseph K BelanoffCEOSell2,924$60.91$178,100.84 3/3/2025Sean MaduckInsiderSell18,303$60.69$1,110,809.07 2/10/2025Daniel N. Swisher, Jr.DirectorSell2,200$68.08$149,776.00 1/10/2025Daniel N. Swisher, Jr.DirectorSell2,200$50.54$111,188.00 1/2/2025Sean MaduckInsiderSell20,000$50.39$1,007,800.00 12/10/2024Daniel N. Swisher, Jr.DirectorSell2,200$59.46$130,812.00 11/22/2024Joseph Douglas LyonInsiderSell1,411$56.72$80,031.92 The Robotics Revolution has arrived … and one $7 stock could take off as a result. (Ad)Something big is brewing in Washington. According to my research, an executive order from President Trump could be just weeks away. And it holds the potential to trigger one of the most explosive tech booms in US history. At the center of it all? Robots. Not the kind that clean your house or pour you coffee. But the kind that could reshape entire industries, add $1.2 trillion per year to the US economy, and affect 65 million American lives — just in the next year.This little-known company holds nearly 100 patents and trades for around $711/11/2024Daniel N. Swisher, Jr.DirectorSell2,200$59.88$131,736.00 11/4/2024William GuyerInsiderSell3,394$48.97$166,204.18 11/1/2024William GuyerInsiderSell6,606$48.97$323,495.82 10/1/2024Gary Charles RobbInsiderSell11,000$46.28$509,080.00 9/3/2024William GuyerInsiderSell10,000$35.30$353,000.00 8/26/2024Gary Charles RobbInsiderSell3,101$35.71$110,736.71 (Data available from 1/1/2013 forward) CORT Insider Trading Activity - Frequently Asked Questions Who is on Corcept Therapeutics' Insider Roster? The list of insiders at Corcept Therapeutics includes Daniel N. Swisher, Jr., David L Mahoney, Gary Charles Robb, Hazel Hunt, Joseph Douglas Lyon, Joseph K Belanoff, Sean Maduck, and William Guyer. Learn more on insiders at CORT. What percentage of Corcept Therapeutics stock is owned by insiders? 20.80% of Corcept Therapeutics stock is owned by insiders. Learn more on CORT's insider holdings. Which Corcept Therapeutics insiders have been selling company stock? The following insiders have sold CORT shares in the last 24 months: Daniel N. Swisher, Jr. ($1,957,086.50), David L. Mahoney ($2,030,338.96), Gary Charles Robb ($990,385.58), Joseph Douglas Lyon ($2,843,881.16), Joseph K Belanoff ($12,639,960.05), Sean Maduck ($23,871,173.59), and William Guyer ($8,794,597.23). How much insider selling is happening at Corcept Therapeutics? Insiders have sold a total of 897,877 Corcept Therapeutics shares in the last 24 months for a total of $53,127,423.07 sold. Corcept Therapeutics Key ExecutivesDr. Joseph K. Belanoff M.D. (Age 67)Co-Founder, President, CEO & Director Compensation: $2.43MMr. Atabak Mokari (Age 47)CFO & Treasurer Compensation: $863.03kMr. Sean Maduck (Age 47)President of Endocrinology Compensation: $1.05M8 recent tradesDr. William Guyer Pharm.D. (Age 56)Chief Development Officer Compensation: $1.03MMr. Gary Charles Robb (Age 61)Chief Business Officer & Secretary Compensation: $1.08MMr. Joseph Douglas Lyon (Age 46)Chief Accounting & Technology Officer 6 recent tradesDr. Hazel Hunt Ph.D. (Age 64)Chief Scientific Officer Compensation: $895.16kMs. Amy FloodChief Human Resources & Communications OfficerMs. Monica Tellado (Age 51)President of Emerging Markets Mr. Roberto W. VieiraPresident of Oncology More Insider Trading Tools from MarketBeat Related Companies RPRX Insider Ownership JAZZ Insider Ownership PRGO Insider Ownership SUPN Insider Ownership PCRX Insider Ownership NKTR Insider Ownership OMER Insider Ownership ASMB Insider Ownership CPIX Insider Ownership LLY Insider Ownership Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles 5 Stocks Insiders Are Selling That Analysts Say BuyStrategy Insiders Buy In While Analysts Predict Big UpsideThe Bottom Is in For These 3 Small-Cap Stocks Insiders Are Buying3 Catalysts Driving Plug Power’s Turnaround CaseInsider Selling Hits Market Leaders—Should You Be Worried? This page (NASDAQ:CORT) was last updated on 8/15/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Corcept Therapeutics Incorporated Please log in to your account or sign up in order to add this asset to your watchlist. Share Corcept Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access